VHT holdings
Vanguard Health Care ETF
Positions
407 stored of 407 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 101 | Chemed Corp | US16359R1032 | 16359R103 | 0.095% | $18.1M | Equity (common) | Corporate | United States | USD |
| 102 | Glaukos Corp | US3773221029 | 377322102 | 0.094% | $17.8M | Equity (common) | Corporate | United States | USD |
| 103 | Bio-Rad Laboratories Inc BIO-RAD LABS-A | US0905722072 | 090572207 | 0.092% | $17.5M | Equity (common) | Corporate | United States | USD |
| 104 | TG Therapeutics Inc | US88322Q1085 | 88322Q108 | 0.091% | $17.2M | Equity (common) | Corporate | United States | USD |
| 105 | Teleflex Inc | US8793691069 | 879369106 | 0.090% | $17.1M | Equity (common) | Corporate | United States | USD |
| 106 | PTC Therapeutics Inc | US69366J2006 | 69366J200 | 0.084% | $16.0M | Equity (common) | Corporate | United States | USD |
| 107 | Hims & Hers Health Inc | US4330001060 | 433000106 | 0.082% | $15.5M | Equity (common) | Corporate | United States | USD |
| 108 | Rhythm Pharmaceuticals Inc | US76243J1051 | 76243J105 | 0.079% | $15.0M | Equity (common) | Corporate | United States | USD |
| 109 | Protagonist Therapeutics Inc | US74366E1029 | 74366E102 | 0.079% | $15.0M | Equity (common) | Corporate | United States | USD |
| 110 | Tempus AI Inc TEMPUS AI INC-A | US88023B1035 | 88023B103 | 0.074% | $14.0M | Equity (common) | Corporate | United States | USD |
| 111 | Ligand Pharmaceuticals Inc | US53220K5048 | 53220K504 | 0.073% | $13.8M | Equity (common) | Corporate | United States | USD |
| 112 | Nuvalent Inc NUVALENT INC-A | US6707031075 | 670703107 | 0.070% | $13.2M | Equity (common) | Corporate | United States | USD |
| 113 | Sotera Health Co | US83601L1026 | 83601L102 | 0.069% | $13.1M | Equity (common) | Corporate | United States | USD |
| 114 | LivaNova PLC | GB00BYMT0J19 | G5509L101 | 0.064% | $12.1M | Equity (common) | Corporate | United States | USD |
| 115 | Twist Bioscience Corp | US90184D1000 | 90184D100 | 0.064% | $12.1M | Equity (common) | Corporate | United States | USD |
| 116 | Travere Therapeutics Inc | US89422G1076 | 89422G107 | 0.063% | $12.0M | Equity (common) | Corporate | United States | USD |
| 117 | Envista Holdings Corp | US29415F1049 | 29415F104 | 0.062% | $11.7M | Equity (common) | Corporate | United States | USD |
| 118 | Kymera Therapeutics Inc | US5015751044 | 501575104 | 0.061% | $11.7M | Equity (common) | Corporate | United States | USD |
| 119 | Mirum Pharmaceuticals Inc | US6047491013 | 604749101 | 0.061% | $11.5M | Equity (common) | Corporate | United States | USD |
| 120 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund Vanguard Market Liquidity Fund | Not reported | Not reported | 0.061% | $11.5M | Short-term investment vehicles (cash funds) | Corporate | United States | USD |
| 121 | Indivior Pharmaceuticals Inc | US45579U1097 | 45579U109 | 0.060% | $11.5M | Equity (common) | Corporate | United States | USD |
| 122 | Liquidia Corp | US53635D2027 | 53635D202 | 0.060% | $11.3M | Equity (common) | Corporate | United States | USD |
| 123 | Merit Medical Systems Inc | US5898891040 | 589889104 | 0.059% | $11.2M | Equity (common) | Corporate | United States | USD |
| 124 | IRhythm Holdings Inc | US4500561067 | 450056106 | 0.058% | $11.0M | Equity (common) | Corporate | United States | USD |
| 125 | RadNet Inc | US7504911022 | 750491102 | 0.058% | $11.0M | Equity (common) | Corporate | United States | USD |
| 126 | Veracyte Inc | US92337F1075 | 92337F107 | 0.058% | $11.0M | Equity (common) | Corporate | United States | USD |
| 127 | Catalyst Pharmaceuticals Inc | US14888U1016 | 14888U101 | 0.058% | $10.9M | Equity (common) | Corporate | United States | USD |
| 128 | Spyre Therapeutics Inc | US00773J2024 | 00773J202 | 0.057% | $10.8M | Equity (common) | Corporate | United States | USD |
| 129 | Viking Therapeutics Inc | US92686J1060 | 92686J106 | 0.056% | $10.6M | Equity (common) | Corporate | United States | USD |
| 130 | Organon & Co | US68622V1061 | 68622V106 | 0.055% | $10.4M | Equity (common) | Corporate | United States | USD |
| 131 | Option Care Health Inc | US68404L2016 | 68404L201 | 0.053% | $10.0M | Equity (common) | Corporate | United States | USD |
| 132 | Dianthus Therapeutics Inc | US2528281080 | 252828108 | 0.051% | $9.8M | Equity (common) | Corporate | United States | USD |
| 133 | ICU Medical Inc | US44930G1076 | 44930G107 | 0.050% | $9.6M | Equity (common) | Corporate | United States | USD |
| 134 | Crinetics Pharmaceuticals Inc | US22663K1079 | 22663K107 | 0.050% | $9.6M | Equity (common) | Corporate | United States | USD |
| 135 | Haemonetics Corp | US4050241003 | 405024100 | 0.050% | $9.5M | Equity (common) | Corporate | United States | USD |
| 136 | Integer Holdings Corp | US45826H1095 | 45826H109 | 0.050% | $9.4M | Equity (common) | Corporate | United States | USD |
| 137 | Apogee Therapeutics Inc | US03770N1019 | 03770N101 | 0.050% | $9.4M | Equity (common) | Corporate | United States | USD |
| 138 | Scholar Rock Holding Corp | US80706P1030 | 80706P103 | 0.049% | $9.2M | Equity (common) | Corporate | United States | USD |
| 139 | Beam Therapeutics Inc | US07373V1052 | 07373V105 | 0.048% | $9.0M | Equity (common) | Corporate | United States | USD |
| 140 | 10X Genomics Inc 10X GENOMICS I-A | US88025U1097 | 88025U109 | 0.047% | $8.9M | Equity (common) | Corporate | United States | USD |
| 141 | Cogent Biosciences Inc | US19240Q2012 | 19240Q201 | 0.046% | $8.8M | Equity (common) | Corporate | United States | USD |
| 142 | Denali Therapeutics Inc | US24823R1059 | 24823R105 | 0.046% | $8.8M | Equity (common) | Corporate | United States | USD |
| 143 | Brookdale Senior Living Inc BROOKDALE SR | US1124631045 | 112463104 | 0.046% | $8.7M | Equity (common) | Corporate | United States | USD |
| 144 | Concentra Group Holdings Parent Inc | US20603L1026 | 20603L102 | 0.045% | $8.6M | Equity (common) | Corporate | United States | USD |
| 145 | Celcuity Inc | US15102K1007 | 15102K100 | 0.044% | $8.3M | Equity (common) | Corporate | United States | USD |
| 146 | Summit Therapeutics Inc | US86627T1088 | 86627T108 | 0.043% | $8.1M | Equity (common) | Corporate | United States | USD |
| 147 | Immunovant Inc | US45258J1025 | 45258J102 | 0.042% | $8.1M | Equity (common) | Corporate | United States | USD |
| 148 | CG oncology Inc | US1569441009 | 156944100 | 0.042% | $8.0M | Equity (common) | Corporate | United States | USD |
| 149 | Supernus Pharmaceuticals Inc | US8684591089 | 868459108 | 0.042% | $7.9M | Equity (common) | Corporate | United States | USD |
| 150 | Doximity Inc DOXIMITY INC-A | US26622P1075 | 26622P107 | 0.042% | $7.9M | Equity (common) | Corporate | United States | USD |
| 151 | ImmunityBio Inc | US45256X1037 | 45256X103 | 0.041% | $7.8M | Equity (common) | Corporate | United States | USD |
| 152 | Alignment Healthcare Inc | US01625V1044 | 01625V104 | 0.041% | $7.7M | Equity (common) | Corporate | United States | USD |
| 153 | ACADIA Pharmaceuticals Inc | US0042251084 | 004225108 | 0.041% | $7.7M | Equity (common) | Corporate | United States | USD |
| 154 | GRAIL Inc | US3847471014 | 384747101 | 0.040% | $7.5M | Equity (common) | Corporate | United States | USD |
| 155 | National HealthCare Corp NATL HEALTHCARE | US6359061008 | 635906100 | 0.038% | $7.3M | Equity (common) | Corporate | United States | USD |
| 156 | Arcutis Biotherapeutics Inc | US03969K1088 | 03969K108 | 0.037% | $7.1M | Equity (common) | Corporate | United States | USD |
| 157 | Ideaya Biosciences Inc | US45166A1025 | 45166A102 | 0.037% | $7.0M | Equity (common) | Corporate | United States | USD |
| 158 | Prestige Consumer Healthcare Inc | US74112D1019 | 74112D101 | 0.036% | $6.9M | Equity (common) | Corporate | United States | USD |
| 159 | Waystar Holding Corp | US9467841055 | 946784105 | 0.036% | $6.9M | Equity (common) | Corporate | United States | USD |
| 160 | Dyne Therapeutics Inc | US26818M1080 | 26818M108 | 0.035% | $6.7M | Equity (common) | Corporate | United States | USD |
| 161 | Arcus Biosciences Inc | US03969F1093 | 03969F109 | 0.035% | $6.6M | Equity (common) | Corporate | United States | USD |
| 162 | Erasca Inc | US29479A1088 | 29479A108 | 0.034% | $6.5M | Equity (common) | Corporate | United States | USD |
| 163 | TransMedics Group Inc | US89377M1099 | 89377M109 | 0.034% | $6.5M | Equity (common) | Corporate | United States | USD |
| 164 | Privia Health Group Inc | US74276R1023 | 74276R102 | 0.033% | $6.3M | Equity (common) | Corporate | United States | USD |
| 165 | Celldex Therapeutics Inc | US15117B2025 | 15117B202 | 0.033% | $6.3M | Equity (common) | Corporate | United States | USD |
| 166 | Progyny Inc | US74340E1038 | 74340E103 | 0.033% | $6.3M | Equity (common) | Corporate | United States | USD |
| 167 | Amneal Pharmaceuticals Inc AMNEAL PHARM INC | US03168L1052 | 03168L105 | 0.033% | $6.3M | Equity (common) | Corporate | United States | USD |
| 168 | DENTSPLY SIRONA Inc | US24906P1093 | 24906P109 | 0.033% | $6.3M | Equity (common) | Corporate | United States | USD |
| 169 | Ultragenyx Pharmaceutical Inc | US90400D1081 | 90400D108 | 0.033% | $6.2M | Equity (common) | Corporate | United States | USD |
| 170 | Immunome Inc | US45257U1088 | 45257U108 | 0.032% | $6.1M | Equity (common) | Corporate | United States | USD |
| 171 | LeMaitre Vascular Inc | US5255582018 | 525558201 | 0.032% | $6.1M | Equity (common) | Corporate | United States | USD |
| 172 | Acadia Healthcare Co Inc | US00404A1097 | 00404A109 | 0.032% | $6.1M | Equity (common) | Corporate | United States | USD |
| 173 | Nektar Therapeutics | US6402683063 | 640268306 | 0.031% | $6.0M | Equity (common) | Corporate | United States | USD |
| 174 | Omnicell Inc | US68213N1090 | 68213N109 | 0.031% | $5.9M | Equity (common) | Corporate | United States | USD |
| 175 | Definium Therapeutics Inc | CA24477V1058 | 24477V105 | 0.031% | $5.8M | Equity (common) | Corporate | United States | USD |
| 176 | Tarsus Pharmaceuticals Inc | US87650L1035 | 87650L103 | 0.030% | $5.7M | Equity (common) | Corporate | United States | USD |
| 177 | CorVel Corp | US2210061097 | 221006109 | 0.030% | $5.7M | Equity (common) | Corporate | United States | USD |
| 178 | ADMA Biologics Inc | US0008991046 | 000899104 | 0.030% | $5.7M | Equity (common) | Corporate | United States | USD |
| 179 | Neogen Corp | US6404911066 | 640491106 | 0.029% | $5.6M | Equity (common) | Corporate | United States | USD |
| 180 | Pediatrix Medical Group Inc | US58502B1061 | 58502B106 | 0.029% | $5.6M | Equity (common) | Corporate | United States | USD |
| 181 | BioCryst Pharmaceuticals Inc | US09058V1035 | 09058V103 | 0.029% | $5.5M | Equity (common) | Corporate | United States | USD |
| 182 | Select Medical Holdings Corp | US81619Q1058 | 81619Q105 | 0.029% | $5.5M | Equity (common) | Corporate | United States | USD |
| 183 | Oruka Therapeutics Inc | US6876041087 | 687604108 | 0.029% | $5.5M | Equity (common) | Corporate | United States | USD |
| 184 | Axogen Inc | US05463X1063 | 05463X106 | 0.029% | $5.5M | Equity (common) | Corporate | United States | USD |
| 185 | Edgewise Therapeutics Inc | US28036F1057 | 28036F105 | 0.029% | $5.4M | Equity (common) | Corporate | United States | USD |
| 186 | Novocure Ltd | JE00BYSS4X48 | G6674U108 | 0.029% | $5.4M | Equity (common) | Corporate | United States | USD |
| 187 | Intellia Therapeutics Inc | US45826J1051 | 45826J105 | 0.028% | $5.4M | Equity (common) | Corporate | United States | USD |
| 188 | Relay Therapeutics Inc | US75943R1023 | 75943R102 | 0.028% | $5.4M | Equity (common) | Corporate | United States | USD |
| 189 | Sarepta Therapeutics Inc | US8036071004 | 803607100 | 0.028% | $5.3M | Equity (common) | Corporate | United States | USD |
| 190 | Kiniksa Pharmaceuticals International Plc | GB00BRXB0C07 | G52694109 | 0.028% | $5.2M | Equity (common) | Corporate | United States | USD |
| 191 | Adaptive Biotechnologies Corp | US00650F1093 | 00650F109 | 0.027% | $5.2M | Equity (common) | Corporate | United States | USD |
| 192 | PACS Group Inc | US69380Q1076 | 69380Q107 | 0.027% | $5.2M | Equity (common) | Corporate | United States | USD |
| 193 | Aurinia Pharmaceuticals Inc | CA05156V1022 | 05156V102 | 0.027% | $5.2M | Equity (common) | Corporate | United States | USD |
| 194 | Astrana Health Inc | US03763A2078 | 03763A207 | 0.027% | $5.1M | Equity (common) | Corporate | United States | USD |
| 195 | Addus HomeCare Corp | US0067391062 | 006739106 | 0.027% | $5.1M | Equity (common) | Corporate | United States | USD |
| 196 | Disc Medicine Inc | US2546041011 | 254604101 | 0.027% | $5.1M | Equity (common) | Corporate | United States | USD |
| 197 | Clover Health Investments Corp | US18914F1030 | 18914F103 | 0.027% | $5.1M | Equity (common) | Corporate | United States | USD |
| 198 | Vericel Corp | US92346J1088 | 92346J108 | 0.027% | $5.1M | Equity (common) | Corporate | United States | USD |
| 199 | Agios Pharmaceuticals Inc | US00847X1046 | 00847X104 | 0.026% | $4.9M | Equity (common) | Corporate | United States | USD |
| 200 | UFP Technologies Inc | US9026731029 | 902673102 | 0.025% | $4.8M | Equity (common) | Corporate | United States | USD |